Thermo Fisher Scientific | TMO - Current Assets


Thermo Fisher Scientific reported $23.36B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Agilent USD 4.76B 148M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Bio Techne USD 688.05M 50.62M Mar/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Danaher USD 13.38B 554M Jun/2026
Dentsply International USD 1.85B 178M Mar/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
General Electric Aerospace USD 39.7B 664M Jun/2026
Henry Schein USD 4.6B 104M Jun/2026
Illumina USD 2.83B 96M Jun/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Laboratory Of America USD 3.81B 743.9M Jun/2026
Medtronic USD 24.07B 75M Dec/2025
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Olympus JPY 706.31B 53.66B Mar/2026
OraSure Technologies USD 240.78M 21.13M Mar/2026
Quest Diagnostics USD 2.84B 278M Jun/2026
Repligen USD 1.2B 39.19M Jun/2026
Revvity USD 2.3B 169.4M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Veracyte USD 574.78M 52.6M Jun/2026
Waters USD 3.9B 186M Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026